Copyright Reports & Markets. All rights reserved.

Global Tamsulosin Hydrochloride Sustained Release Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Tamsulosin Hydrochloride Sustained Release Capsules
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Original Drug
    • 1.3.3 Generic Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size & Forecast
    • 1.5.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity (2018-2029)
    • 1.5.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Astellas Pharma Inc.
    • 2.1.1 Astellas Pharma Inc. Details
    • 2.1.2 Astellas Pharma Inc. Major Business
    • 2.1.3 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.1.4 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Astellas Pharma Inc. Recent Developments/Updates
  • 2.2 Shenzhen Wanhe Pharmaceutical Co., Ltd.
    • 2.2.1 Shenzhen Wanhe Pharmaceutical Co., Ltd. Details
    • 2.2.2 Shenzhen Wanhe Pharmaceutical Co., Ltd. Major Business
    • 2.2.3 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.2.4 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Shenzhen Wanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.3 Zhejiang Conba Pharmaceutical Co., Ltd.
    • 2.3.1 Zhejiang Conba Pharmaceutical Co., Ltd. Details
    • 2.3.2 Zhejiang Conba Pharmaceutical Co., Ltd. Major Business
    • 2.3.3 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.3.4 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Zhejiang Conba Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.4 Guangdong Huanan Pharmaceutical Group Co., Ltd.
    • 2.4.1 Guangdong Huanan Pharmaceutical Group Co., Ltd. Details
    • 2.4.2 Guangdong Huanan Pharmaceutical Group Co., Ltd. Major Business
    • 2.4.3 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.4.4 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Guangdong Huanan Pharmaceutical Group Co., Ltd. Recent Developments/Updates
  • 2.5 Hailisheng Group Co., Ltd.
    • 2.5.1 Hailisheng Group Co., Ltd. Details
    • 2.5.2 Hailisheng Group Co., Ltd. Major Business
    • 2.5.3 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.5.4 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Hailisheng Group Co., Ltd. Recent Developments/Updates
  • 2.6 Shanghai Anbison Pharmaceutical Technology Co., Ltd.
    • 2.6.1 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Details
    • 2.6.2 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Major Business
    • 2.6.3 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.6.4 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
  • 2.7 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
    • 2.7.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Details
    • 2.7.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Major Business
    • 2.7.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.7.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.8 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
    • 2.8.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Details
    • 2.8.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Major Business
    • 2.8.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.8.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
  • 2.9 Sandoz Canada
    • 2.9.1 Sandoz Canada Details
    • 2.9.2 Sandoz Canada Major Business
    • 2.9.3 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.9.4 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Sandoz Canada Recent Developments/Updates
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.10.4 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Sanofi Recent Developments/Updates
  • 2.11 Murli Krishna Pharma
    • 2.11.1 Murli Krishna Pharma Details
    • 2.11.2 Murli Krishna Pharma Major Business
    • 2.11.3 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.11.4 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Murli Krishna Pharma Recent Developments/Updates
  • 2.12 DM Pharma
    • 2.12.1 DM Pharma Details
    • 2.12.2 DM Pharma Major Business
    • 2.12.3 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product and Services
    • 2.12.4 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 DM Pharma Recent Developments/Updates

3 Competitive Environment: Tamsulosin Hydrochloride Sustained Release Capsules by Manufacturer

  • 3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Manufacturer (2018-2023)
  • 3.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Tamsulosin Hydrochloride Sustained Release Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Tamsulosin Hydrochloride Sustained Release Capsules Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Tamsulosin Hydrochloride Sustained Release Capsules Manufacturer Market Share in 2022
  • 3.5 Tamsulosin Hydrochloride Sustained Release Capsules Market: Overall Company Footprint Analysis
    • 3.5.1 Tamsulosin Hydrochloride Sustained Release Capsules Market: Region Footprint
    • 3.5.2 Tamsulosin Hydrochloride Sustained Release Capsules Market: Company Product Type Footprint
    • 3.5.3 Tamsulosin Hydrochloride Sustained Release Capsules Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Region
    • 4.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Region (2018-2029)
    • 4.1.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price by Region (2018-2029)
  • 4.2 North America Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value (2018-2029)
  • 4.3 Europe Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value (2018-2029)
  • 4.5 South America Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Type (2018-2029)
  • 5.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Type (2018-2029)
  • 5.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Application (2018-2029)
  • 6.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Application (2018-2029)
  • 6.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Type (2018-2029)
  • 7.2 North America Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Application (2018-2029)
  • 7.3 North America Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country
    • 7.3.1 North America Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Type (2018-2029)
  • 8.2 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Application (2018-2029)
  • 8.3 Europe Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country
    • 8.3.1 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Region
    • 9.3.1 Asia-Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Type (2018-2029)
  • 10.2 South America Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Application (2018-2029)
  • 10.3 South America Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country
    • 10.3.1 South America Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country
    • 11.3.1 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Tamsulosin Hydrochloride Sustained Release Capsules Market Drivers
  • 12.2 Tamsulosin Hydrochloride Sustained Release Capsules Market Restraints
  • 12.3 Tamsulosin Hydrochloride Sustained Release Capsules Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tamsulosin Hydrochloride Sustained Release Capsules and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tamsulosin Hydrochloride Sustained Release Capsules
  • 13.3 Tamsulosin Hydrochloride Sustained Release Capsules Production Process
  • 13.4 Tamsulosin Hydrochloride Sustained Release Capsules Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tamsulosin Hydrochloride Sustained Release Capsules Typical Distributors
  • 14.3 Tamsulosin Hydrochloride Sustained Release Capsules Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tamsulosin Hydrochloride Sustained Release Capsules market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Tamsulosin Hydrochloride Sustained Release Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Tamsulosin Hydrochloride Sustained Release Capsules market size and forecasts, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2018-2029
    Global Tamsulosin Hydrochloride Sustained Release Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2018-2029
    Global Tamsulosin Hydrochloride Sustained Release Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2018-2029
    Global Tamsulosin Hydrochloride Sustained Release Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (K Boxes), and ASP (US$/Box), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tamsulosin Hydrochloride Sustained Release Capsules
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tamsulosin Hydrochloride Sustained Release Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma Inc., Shenzhen Wanhe Pharmaceutical Co., Ltd., Zhejiang Conba Pharmaceutical Co., Ltd., Guangdong Huanan Pharmaceutical Group Co., Ltd. and Hailisheng Group Co., Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Tamsulosin Hydrochloride Sustained Release Capsules market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Original Drug
    Generic Drug
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Astellas Pharma Inc.
    Shenzhen Wanhe Pharmaceutical Co., Ltd.
    Zhejiang Conba Pharmaceutical Co., Ltd.
    Guangdong Huanan Pharmaceutical Group Co., Ltd.
    Hailisheng Group Co., Ltd.
    Shanghai Anbison Pharmaceutical Technology Co., Ltd.
    Jiangxi Shanxiang Pharmaceutical Co., Ltd.
    Jiangsu Hengrui Pharmaceuticals Co.,ltd.
    Sandoz Canada
    Sanofi
    Murli Krishna Pharma
    DM Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tamsulosin Hydrochloride Sustained Release Capsules product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, with price, sales, revenue and global market share of Tamsulosin Hydrochloride Sustained Release Capsules from 2018 to 2023.
    Chapter 3, the Tamsulosin Hydrochloride Sustained Release Capsules competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tamsulosin Hydrochloride Sustained Release Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tamsulosin Hydrochloride Sustained Release Capsules market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tamsulosin Hydrochloride Sustained Release Capsules.
    Chapter 14 and 15, to describe Tamsulosin Hydrochloride Sustained Release Capsules sales channel, distributors, customers, research findings and conclusion.

    Buy now